GlassScriptPhysician profile
Timothy M Pierce
NPI 1316007115
$800.50
in general payments reported to CMS, 2019-2025
8 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $13.11 · 2021: $50.00 · 2022: $107 · 2023: $344 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401 · Education: $32.78 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.61 |
| Education | $32.78 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $235.10 | 2022-2023 | Spark |
| Nobel Biocare USA | $153.10 | 2023 | Nobelactive |
| 3m Company | $91.31 | 2019 | |
| USA Angelalign Technology Corp | $76.17 | 2025 | |
| Gc America INC. | $68.24 | 2021-2025 | Chic, Legend |
| Zimmer Biomet Holdings, INC. | $66.23 | 2019 | |
| Align Technology, INC. | $64.46 | 2019-2023 | Invisalign, Itero |
| Colgate Oral Pharmaceuticals, INC. | $45.89 | 2020-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.